MICB and neoplasm: It has been shown that tumour cells and CAFs escape immune cell attack by expressing high levels of PD‐L1 and PD‐L2, and shedding NKG2D ligands (MICA, MICB and ULBP1‐6) from the cell surface through proteolytic cleavage.36